Horiba Medical Exhibits New Generation of Automated Hematology Analyzers at MEDLAB Middle East 2021

On display at the event were the Yumizen H2500, Yumizen SPS and Yumizen P8000 - the new generation of Horiba automated hematology analyzers that answers customers’ expectations of solid and reliable diagnostic technology as well as rapid and consistent results. Some of their features include a real throughput of 120 samples per hour for CBC-DIFF, NRBC included, sampling volume of 110μl (CBC, DIFF, BF) and 75μL (Slide), only six reagents, automatic 360° rotative sample mixing for perfect homogeneity, two PLT technologies - Impedance & Optical extinction – and three WBC counts in CBC and differential modes. All the instruments are compatible with the HELO Solution (HORIBA Evolutive Laboratory Organization).

Horiba also showcased its Yumizen H500 and H550 analyzers that have been designed to deliver a rapid and comprehensive hematology report with a throughput of 60 tests/hour, 40 tubes autonomy with continuous loading, urgent manual mode; and for running samples through multi analysis modes and sampling. Based on color codes, minimum operation and quality flagging messages, the ergonomics of the new Yumizen H500 and H550 are perfectly dedicated to users of small size laboratories such as emergency rooms or physician office labs. With its menu of extensive parameters and enhanced clinical performances the new Yumizen H500 and H550 analyzers are capable of meeting the demands of a variety of clinical lab environments and clinical settings: routine hematology, satellites labs, oncology care, blood banks.

In addition, Horiba highlighted the Microsemi LC-667G hematology analyzer featuring the exclusive concept of simultaneous blood analysis + CRP measurement, along with data management. It is the first hematology analyzer to offer malaria screening flag combined with CBC count. The Malaria screening flag with high sensitivity alerts the physician about suspicion of malaria infection and is available in CBC or CBC+CRP routine use without any specific reagent or dedicated mode. The added value is part of a complete solution of using the MicrosEmi CRP as an infectious differentiator.

Related Links:
Horiba Medical